Home LiteratureArticle Details
PMID: 17014580 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease.

Alimentary pharmacology & therapeutics ·Vol. 24 ·No. 8 ·2006-10-15 ·Pages 1215-22

Wong VW, Hui AY, Tsang SW, Chan JL, Wong GL, Chan AW, So WY, Cheng AY, Tong PC, Chan FK, Sung JJ, Chan HL

Abstract

Non-alcoholic fatty liver disease is prevalent in affluent countries and is strongly associated with metabolic syndrome. To study the prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease. 73 consecutive patients with biopsy-proven non-alcoholic fatty liver disease and no history of diabetes underwent comprehensive metabolic screening. Diagnosis of diabetes and impaired glucose regulation was based on the 2006 American Diabetes Association criteria. The prevalence of undiagnosed diabetes and impaired glucose tolerance in non-alcoholic fatty liver disease patients was 33% and 29%, respectively. Among patients with 2-h plasma glucose above 7.8 mm, 47% had normal fasting glucose (below 5.6 mm). Impaired glucose tolerance was more common in patients with non-alcoholic steatohepatitis than those with simple hepatic steatosis (P = 0.036), and 2-h plasma glucose correlated with fibrosis stage (Spearman coefficient: 0.25, P = 0.046). In a binary logistic regression analysis, high fasting glucose and low high-density lipoprotein cholesterol were independent factors associated with diabetes. Nevertheless, if oral glucose tolerance test was only performed in non-alcoholic fatty liver disease patients with impaired fasting glucose, 20.8% of diabetes cases would be missed. Isolated postchallenge hyperglycaemia is common among Chinese non-alcoholic fatty liver disease patients without history of diabetes. It is associated with histological severe disease, and cannot be accurately predicted by any fasting glucose cut-off.

MeSH Terms
Blood Glucose/analysis Cholesterol, HDL/blood Diabetes Complications/diagnosis,epidemiology,pathology Fatty Liver/complications,epidemiology,pathology Female Glucose Tolerance Test/methods Hong Kong/epidemiology Humans Hyperglycemia/complications,epidemiology,pathology Insulin Resistance Liver/pathology Male Middle Aged Prevalence Prospective Studies
Chemicals
Blood Glucose Cholesterol, HDL
Authors & Affiliations
12 authors, click to expand affiliations / ORCID
Wong V W S
Institute of Digestive Diseases, The Chinese University of Hong Kong, Prince of Wales Hospital, 30-32 Ngan Shing Street, Shatin, Hong Kong SAR.
Hui A Y
Tsang S W C
Chan J L Y
Wong G L H
Chan A W H
So W Y
Cheng A Y S
Tong P C Y
Chan F K L
Sung J J Y
Chan H L Y
Article Info
Journal
Alimentary pharmacology & therapeutics
Abbr.
Aliment Pharmacol Ther
ISSN
0269-2813
Published
2006-10-15
Pages
1215-22
Language
English
Region
England
NLM ID
8707234
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]